No Data
No Data
No Data
Eiger BioPharmaceuticals Issues Cautionary Chapter 11 Reports
Amylyx Inks Deal to Buy Eiger's GLP-1 Targeting Drug
Express News | Eiger BioPharmaceuticals Inc - Asset Purchase Agreement for $35.1 Million, Plus Aggregate Amount of Determined Cure Costs and Assumed Liabilities
Express News | Eiger BioPharmaceuticals Inc - Company and Amylyx Entered Into an Asset Purchase Agreement
Express News | Spruce Biosciences- Agreed to Buy All Rights,Title,Interests in,to & Under Some Assets,Interests Used by Eiger BioPharmaceuticals Related to Avexitide
Eiger BioPharmaceuticals Cautions Investors Amid Bankruptcy
No Data